KYMR (NASDAQ) director/insider plans 4,600-share option exercise; prior 7,400-share 10b5-1 sale
Rhea-AI Filing Summary
KYMR reported a proposed sale of 4,600 shares of Common Stock via exercise of stock options to be effected on 04/01/2026 through Morgan Stanley Smith Barney LLC. The filing also records prior 10b5-1 sales by Elena Ridloff of 7,400 shares on 03/31/2026 for $631,738.74.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 sale notice tied to option exercise and recent 10b5-1 activity.
The filing documents a planned disposition of 4,600 shares by exercise of stock options on 04/01/2026 and discloses earlier Rule 10b5-1 sales of 7,400 shares on 03/31/2026 for $631,738.74. This pattern is consistent with executive liquidity actions rather than operating results.
Cash‑flow treatment is stated as Cash for the option exercise. Timing and mechanics are explicit in the excerpt; subsequent filings would show actual settlement details and post‑transaction holdings.